🇺🇸 FDA
Patent

US 8618259

Polymer-factor VIII conjugate compositions

granted A61KA61K38/37A61K47/10

Quick answer

US patent 8618259 (Polymer-factor VIII conjugate compositions) held by Nektar Therapeutics expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K38/37, A61K47/10, A61K47/60, A61P